Elon Musk’s brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval. The FDA nod “represents an important first step that will one day allow our technology to…Read More
Related Posts
Librarelated Sui blockchain fixes critical bug that put billions at risk
The Sui blockchain network quietly fixed a bug that could have put “billions of dollars” at risk, according to a May 16 announcement from Zellic, the security firm hired to…
Australia asks if highrisk AI should be banned in surprise consultation
The Australian government has announced a sudden eight-week consultation that will seek to understand whether any “high-risk” artificial intelligence tools should be banned. Other regions including the United States, the…
